平安健康醫療科技有限公司 01833Prospectus Information

Prospectus Information
Company Overview
Stock Name平安健康醫療科技有限公司
Stock Code01833
Company Full Name平安健康醫療科技有限公司
Industry醫療保健
Principal Activities公司主要於中國提供線上醫療及健康服務。
Listing Date2018-05-04
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市凱濱路166號上海平安大廈B座16至19樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.pahtg.com
Share Registrar
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 54.80 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share49.2%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 2,193,293,280
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 54.8
First Day OpenHK$ 57.3
First Day Change-81.53%
First Day Volume68143200.0
First Day Turnover3845500000.0
Use of Proceeds
Use of Proceeds1、約40%的所得款項凈額用于業務拓展; 2、約30%的所得款項凈額用于為我們潛在投資、收購境內公司及與境內公司的策略聯盟以及我們的海外拓展計劃提供資金; 3、約20%的所得款項凈額,用于研發,包括發展我們的信息基礎設施、在國內外招聘高素質的人工智能專業人士及向人工智能人才提供具競爭力的薪酬方案以及與領先的研究機構及大學加強合作及伙拍行業領先的科技公司進行研究及開發; 4、約10%的所得款項凈額,用于營運資金及一般公司用途。
Underwriting Syndicate
Joint Sponsors (2)
花旗环球金融亚洲有限公司 CE AAA137 J.P. Morgan Securities (Far East) Limited CE AAB026
Overall Coordinators (4)
花旗环球金融亚洲有限公司 CE AAA137 J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321 中国平安证券(香港)有限公司 UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (10)
建银国际金融有限公司 CE AJO225 中国国际金融香港证券有限公司 CE AEN894 招商证券(香港)有限公司 CE AAI650 花旗环球金融亚洲有限公司 CE AAA137 中信里昂证券有限公司 CE AAB893 招银国际融资有限公司 CE AVM940 香港上海汇丰银行有限公司 J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321 中国平安证券(香港)有限公司 UBS Securities Hong Kong Limited CE BIN466
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 BlackRock Funds 981,232,360 HKD 11.18% 6 months 2018-11-04
2 CapRe基金 588,732,840 HKD 6.71% 6 months 2018-11-04
3 GIC Private Limited 784,988,080 HKD 8.95% 6 months 2018-11-04
4 Pantai Juara Investments Limited 392,494,040 HKD 4.47% 6 months 2018-11-04
5 Swiss Re Direct Investments Company 392,494,040 HKD 4.47% 6 months 2018-11-04
6 加拿大退休金计划投资委员会 784,988,080 HKD 8.95% 6 months 2018-11-04
7 正大光明控股有限公司 392,494,040 HKD 4.47% 6 months 2018-11-04
Directors & Management
Chairman郭曉濤
Company Secretary臧珞琦
No director data available.
Major Shareholders
Major Shareholders & Holdings中國平安保險(集團)股份有限公司(39.41%);朱孟依(9.37%);幫騏鍵有限公司(8.54%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics